The name Clay Siegall might not ring a bell in most people’s minds. Though this guy has done some amazing things for cancer research, he is definitely not a household name. Fortunately, Clay Siegall isn’t trying to be famous, he’s trying to save lives and this is what separates him from the pack. With a Ph.D in Genetics from George Washington University and a B.S. in Zoology from the University of Maryland, this guy has a brilliant educational background. Siegall just so happens to be one of the founders for Seattle Genetics. This Seattle-based biotech company is the worldwide leader in cancer research. It is located in Seattle, Washington, and it specializes in developing and commercializing antibody-based therapies. These are some of the most innovative drugs of all-time.
Siegall is a man of many titles as he’s a doctor, a scientist, a businessman, a mentor and an author. The guy literally has at least 15 patents at the moment. It seems like there isn’t anything that he can’t do when it comes to medical research. Since Seattle Genetics’ inception back in 1998, he has transformed this once tiny startup business into a mega global powerhouse. Siegall spends a lot of time participating in capital-raising activities. These public and private financings have generated up to $1.2 billion. Much of this money goes right back into the business itself, which equals out to a great return on investment.
Targeted therapies are the new norm and Seattle Genetics produces some of the best. They’re far superior than previous cancer fighting medications, and they’re less harsh on the human body. Siegall has helped the company grow in a number of ways. His ability to make multiple strategic licensing deals is one way that he has pushed the envelope. When it’s all said and done, Clay Siegall will go down as one of the most influential figures in the fight against cancer.